Defects in ETF or ETF-QO result in glutaric acidemia type II, a common fatal disease resulting from the inability to catabolize various fatty acyl-CoAs [23, 24]. Here, TEAD2 is linked to multiple acyl-CoA dehydrogenase deficiency.